Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Yamagishi

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[The role of epigenetics in malignant lymphoma]Makoto Yamagishi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 11, 2018
[Epigenetic aberrations in adult T-cell leukemia/lymphoma and development of a novel EZH1/2 inhibitor]Makoto Yamagishi
International Journal of Hematology|October 14, 2022
The role of epigenetics in T-cell lymphomaMakoto Yamagishi
International Journal of Hematology|November 26, 2025
Genome-epigenome crosstalk in T-cell lymphomas: from maps to mechanismsMakoto Yamagishi
Current Opinion in Oncology|July 1, 2017
Targeting EZH2 in cancer therapyMakoto Yamagishi, Kaoru Uchimaru
Uirusu|November 30, 2012
[miRNA in HTLV-1 related disease]Makoto Yamagishi, Toshiki Watanabe
Frontiers in Microbiology|October 13, 2012
Molecular hallmarks of adult T cell leukemiaMakoto Yamagishi, Toshiki Watanabe
Cancer Science|November 15, 2025
From Genomic and Epigenomic Maps to Medicines in Adult T-Cell Leukemia/LymphomaKako Suzuki, Makoto Yamagishi
Experimental Hematology|December 24, 2025
Polycomb Repressive Complexes as Therapeutic Targets in Hematologic MalignanciesMakoto Yamagishi, Atsushi Iwama, Issay Kitabayashi
Frontiers in Microbiology|August 9, 2018
HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-LymphomaMakoto Yamagishi, Dai Fujikawa, Toshiki Watanabe, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[The role of epigenetics in malignant lymphoma]Makoto Yamagishi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 11, 2018
[Epigenetic aberrations in adult T-cell leukemia/lymphoma and development of a novel EZH1/2 inhibitor]Makoto Yamagishi
International Journal of Hematology|October 14, 2022
The role of epigenetics in T-cell lymphomaMakoto Yamagishi
International Journal of Hematology|November 26, 2025
Genome-epigenome crosstalk in T-cell lymphomas: from maps to mechanismsMakoto Yamagishi
Current Opinion in Oncology|July 1, 2017
Targeting EZH2 in cancer therapyMakoto Yamagishi, Kaoru Uchimaru
Uirusu|November 30, 2012
[miRNA in HTLV-1 related disease]Makoto Yamagishi, Toshiki Watanabe
Frontiers in Microbiology|October 13, 2012
Molecular hallmarks of adult T cell leukemiaMakoto Yamagishi, Toshiki Watanabe
Cancer Science|November 15, 2025
From Genomic and Epigenomic Maps to Medicines in Adult T-Cell Leukemia/LymphomaKako Suzuki, Makoto Yamagishi
Experimental Hematology|December 24, 2025
Polycomb Repressive Complexes as Therapeutic Targets in Hematologic MalignanciesMakoto Yamagishi, Atsushi Iwama, Issay Kitabayashi
Frontiers in Microbiology|August 9, 2018
HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-LymphomaMakoto Yamagishi, Dai Fujikawa, Toshiki Watanabe, et al.
Pageof 6